Overview
Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital.
Dr. Partridge is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, HER-2 Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.
Her clinical research consists of co-authoring 459 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of BRCA Positive Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
75 Francis Street, Boston, MA 02115
450 Brookline Avenue, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
10 Clinical Trials
The General Hospital Corporation
Leif Ellisen is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Ellisen is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. His top areas of expertise are Breast Cancer, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Triple-Negative Breast Cancer. Dr. Ellisen is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Judy Garber is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Garber is rated as a Distinguished provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Li-Fraumeni Syndrome, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Phacomatosis Pigmentokeratotica. Dr. Garber is currently accepting new patients.
Beth Israel Deaconess Medical Center - Hematology/Oncology
Nadine Tung is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Tung is rated as an Elite provider by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Ovarian Cancer, HER-2 Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Partridge isElite. Learn about Breast Cancer.
- Distinguished
- AngiosarcomaDr. Partridge isDistinguished. Learn about Angiosarcoma.
- BRCA Positive Breast CancerDr. Partridge isDistinguished. Learn about BRCA Positive Breast Cancer.
- HER-2 Positive Breast CancerDr. Partridge isDistinguished. Learn about HER-2 Positive Breast Cancer.
- HER2 Negative Breast CancerDr. Partridge isDistinguished. Learn about HER2 Negative Breast Cancer.
- Inflammatory Breast CancerDr. Partridge isDistinguished. Learn about Inflammatory Breast Cancer.
- MenopauseDr. Partridge isDistinguished. Learn about Menopause.
- Advanced
- Breast Cancer in MenDr. Partridge isAdvanced. Learn about Breast Cancer in Men.
- Classical Hodgkin LymphomaDr. Partridge isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Gastric LymphomaDr. Partridge isAdvanced. Learn about Gastric Lymphoma.
- Hodgkin LymphomaDr. Partridge isAdvanced. Learn about Hodgkin Lymphoma.
- Non-Hodgkin LymphomaDr. Partridge isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Acute Myeloblastic Leukemia with MaturationDr. Partridge isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Partridge isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Anal CancerDr. Partridge isExperienced. Learn about Anal Cancer.
- B-Cell LymphomaDr. Partridge isExperienced. Learn about B-Cell Lymphoma.
- Childhood Acute Myeloid LeukemiaDr. Partridge isExperienced. Learn about Childhood Acute Myeloid Leukemia.